Residents of the Cedar Brook subdivision in New Albany met last week with officials from Venture Therapeutics, a company planning to build a facility next to their subdivision, and asked for more landscaping and screening for their homes.

Residents of the Cedar Brook subdivision in New Albany met last week with officials from Venture Therapeutics, a company planning to build a facility next to their subdivision, and asked for more landscaping and screening for their homes.

The company's chief financial officer agreed with their concerns and said the company will change its development plans to accommodate them.

"We listened to the residents and I think they had some valid concerns and questions," said Michael Medors, Venture Therapeutics CFO.

Medors and New Albany officials met with nine Cedar brook residents July 9 to talk about the company's potential 43,000-square-foot facility east of 8000 Walton Parkway. The company plans to build a research facility that will develop new pharmaceuticals.

Medors said he agreed to plant more deciduous trees and evergreens on the north side of the property. Mounds also will be added on that side to shield the building from neighbors. He said the company will consider a similar plan for the east side of the building.

Kathryn Meyer, the city's deputy community development director, said the mounds will be up to 6 feet high.

Venture Therapeutics also has agreed to install timers on lights in the parking lot so the lights will not stay on all night.

"These are simple things that can be addressed and don't make a big impact on the project," Medors said.

The two sides also talked about stormwater retention.

Ann Luczak of 6450 Cedar Brook Drive said the neighbors favor a pond but both sides have agreed a retention system that creates the least amount of mosquitoes should be used.

"Overall, this (meeting) was not a waste of time," said her husband, Scott Luczak.

Meyer said the project still requires an approved final development plan, which will be reviewed by the city's planning commission before going to New Albany City Council for a public vote.

Four residents spoke against the project June 18 at a New Albany Planning Commission meeting. The commission unanimously approved a conditional-use permit for the research facility, with four conditions: that the use be tied to Venture Therapeutics; that the use be limited to a similar type of manufacturing if the company is sold; that the property owner, the New Albany Co., work with neighboring property owners to maintain well integrity during construction; and that landscaping and screening to adjacent neighbors in the Cedar Brook subdivision be considered.

New Albany City Council on June 19 unanimously approved a 100-percent, 15-year abatement on real property taxes for the facility.

Jennifer Chrysler, the city's community development director, said the company is expected to add 110 jobs in five years, which would create a $5.5 million annual payroll.

She said Venture Therapeutics will invest an estimated $21 million in the facility. Over the 15 years of the abatement, the company is anticipated to generate $1.38 million in income-tax revenue, providing $486,000 to the New Albany-Plain Local School District through revenue-sharing agreements, $416,700 to the New Albany Community Authority, which repays infrastructure debt for the business campus, and $486,000 to the city's general fund.